MiMedx (NASDAQ:MDXG) is a processor, marketer, and distributor of human amniotic tissue. Through its "Give the Gift of Healing" program, MiMedx obtains amniotic membrane tissue that would otherwise be discarded. The program allows for mothers, who deliver healthy babies by Cesarean section, to donate the placentas. MiMedx then employs exclusive technology known as the Purion Process, which allows the amniotic tissue to be dehydrated and sterilized. This process allows for an easy to use graft that can be stored at room temperature and has a five-year shelf life. These allografts have proven to be a facilitator of wound healing and are being used to heal lower extremity ulcers, to treat burn victims, and in many other surgical applications....
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|